A Commentary on "Comparative Analysis of Romosozumab Versus Vertebroplasty With Denosumab: Efficacy, Safety, and Secondary Bone Mineral Density Outcomes".
作者信息
Inui Toshihiko
机构信息
Department of Neurosurgery, Kotobuki Social Medical Corporation, Tominaga Hospital, Osaka, Japan.
出版信息
Neurospine. 2025 Mar;22(1):78-80. doi: 10.14245/ns.2550298.149. Epub 2025 Mar 31.
Abstract
摘要
相似文献
1
A Commentary on "Comparative Analysis of Romosozumab Versus Vertebroplasty With Denosumab: Efficacy, Safety, and Secondary Bone Mineral Density Outcomes".
Neurospine. 2025 Mar;22(1):78-80. doi: 10.14245/ns.2550298.149. Epub 2025 Mar 31.
2
Comparative Analysis of Romosozumab Versus Vertebroplasty With Denosumab: Efficacy, Safety, and Secondary Bone Mineral Density Outcomes.
Neurospine. 2025 Mar;22(1):69-77. doi: 10.14245/ns.2449228.614. Epub 2025 Mar 31.
3
Romosozumab efficacy and safety in European patients enrolled in the FRAME trial.
Osteoporos Int. 2022 Dec;33(12):2527-2536. doi: 10.1007/s00198-022-06544-2. Epub 2022 Sep 29.
4
Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis.
Front Endocrinol (Lausanne). 2023 Jul 12;14:1188969. doi: 10.3389/fendo.2023.1188969. eCollection 2023.
5
Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension.
Arch Osteoporos. 2019 Jun 5;14(1):59. doi: 10.1007/s11657-019-0608-z.
6
Verification of efficacy and safety of ibandronate or denosumab for postmenopausal osteoporosis after 12-month treatment with romosozumab as sequential therapy: The prospective VICTOR study.
Bone. 2022 Sep;162:116480. doi: 10.1016/j.bone.2022.116480. Epub 2022 Jul 1.
7
One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study.
J Bone Miner Res. 2019 Mar;34(3):419-428. doi: 10.1002/jbmr.3622. Epub 2018 Dec 3.
8
Denosumab versus romosozumab for postmenopausal osteoporosis treatment.
Sci Rep. 2021 Jun 3;11(1):11801. doi: 10.1038/s41598-021-91248-6.
9
Verifying the effectiveness of romosozumab re-administration on bone mineral density.
J Bone Miner Res. 2025 Feb 2;40(2):201-210. doi: 10.1093/jbmr/zjae196.
10
Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study.
J Bone Miner Res. 2018 Aug;33(8):1397-1406. doi: 10.1002/jbmr.3452. Epub 2018 May 22.
本文引用的文献
1
Comparative Analysis of Romosozumab Versus Vertebroplasty With Denosumab: Efficacy, Safety, and Secondary Bone Mineral Density Outcomes.
Neurospine. 2025 Mar;22(1):69-77. doi: 10.14245/ns.2449228.614. Epub 2025 Mar 31.
2
Comparison of the Clinical Efficacy of Anabolic Agents and Bisphosphonates in the Patients With Osteoporotic Vertebral Fracture: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Neurospine. 2024 Jun;21(2):416-429. doi: 10.14245/ns.2347256.628. Epub 2024 May 2.
3
Comparison of the Efficacy of Romosozumab and Teriparatide for the Management of Osteoporotic Vertebral Compression Fractures.
Neurospine. 2023 Dec;20(4):1217-1223. doi: 10.14245/ns.2347030.515. Epub 2023 Dec 31.
4
Romosozumab versus Teriparatide for the Treatment of Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis through a Grade Analysis of Evidence.
Orthop Surg. 2021 Oct;13(7):1941-1950. doi: 10.1111/os.13136. Epub 2021 Oct 12.
5
Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial.
BMJ. 2018 May 9;361:k1551. doi: 10.1136/bmj.k1551.
6
Percutaneous vertebroplasty for osteoporotic vertebral compression fracture.
Cochrane Database Syst Rev. 2018 Apr 4;4(4):CD006349. doi: 10.1002/14651858.CD006349.pub3.
7
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis.
N Engl J Med. 2017 Oct 12;377(15):1417-1427. doi: 10.1056/NEJMoa1708322. Epub 2017 Sep 11.
8
Romosozumab Treatment in Postmenopausal Women with Osteoporosis.
N Engl J Med. 2016 Oct 20;375(16):1532-1543. doi: 10.1056/NEJMoa1607948. Epub 2016 Sep 18.
9
Predicting delayed union in osteoporotic vertebral fractures with consecutive magnetic resonance imaging in the acute phase: a multicenter cohort study.
Osteoporos Int. 2016 Dec;27(12):3567-3575. doi: 10.1007/s00198-016-3687-3. Epub 2016 Jun 25.
Zotero 插件